Vascular endothelial growth factor regulates the migration of oligodendrocyte precursor cells

J Neurosci. 2011 Jul 20;31(29):10666-70. doi: 10.1523/JNEUROSCI.1944-11.2011.

Abstract

Originally identified as an angiogenic factor, vascular endothelial growth factor (VEGF-A) is now known to play multiple roles in the CNS, including the direct regulation of neuronal and astrocytic functions. Here, we ask whether VEGF-A can also have a novel role in white matter by modulating oligodendrocyte precursor cells (OPCs). OPCs were cultured from rat neonatal cortex. Expression of VEGF-receptor2/KDR/Flk-1 was confirmed with Western blot and immunostaining. VEGF-A did not affect proliferation or differentiation in OPC cultures, but VEGF-A promoted OPC migration in a concentration-dependent manner. Consistent with this migration phenotype, VEGF-A-treated OPCs showed reorganization of actin cytoskeleton in leading-edge processes. VEGF-A-induced migration and actin reorganization were inhibited by an anti-Flk-1 receptor-blocking antibody. Mechanistically, VEGF-A induced binding of focal adhesion kinase (FAK) with paxillin. The FAK inhibitor PF573228 reduced VEGF-A-induced OPC migration. VEGF-A signaling also evoked a transient rise in reactive oxygen species (ROS), and OPC migration was increased when antioxidants were removed from the culture media. Our findings demonstrate that VEGF-A can induce OPC migration via an ROS- and FAK-dependent mechanism, and suggest a novel role for VEGF-A in white-matter maintenance and homeostasis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Animals, Newborn
  • Antigens / metabolism
  • Antioxidants / pharmacology
  • Cell Count
  • Cell Differentiation / drug effects
  • Cell Movement / genetics*
  • Cell Proliferation / drug effects
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Female
  • Gangliosides / metabolism
  • Male
  • Oligodendroglia / drug effects*
  • Oligodendroglia / physiology
  • Paxillin / pharmacokinetics
  • Protein Binding / drug effects
  • Proteoglycans / metabolism
  • Quinolones / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Stem Cells / drug effects*
  • Stem Cells / physiology
  • Sulfones / pharmacology
  • Vascular Endothelial Growth Factor A / pharmacology*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism

Substances

  • 6-(4-(3-(methylsulfonyl)benzylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3,4-dihydroquinolin-2(1H)-one
  • Actins
  • Antigens
  • Antioxidants
  • Enzyme Inhibitors
  • Gangliosides
  • Paxillin
  • Proteoglycans
  • Quinolones
  • Sulfones
  • Vascular Endothelial Growth Factor A
  • chondroitin sulfate proteoglycan 4
  • ganglioside A2B5
  • Vascular Endothelial Growth Factor Receptor-1